Values and preferences of physicians and patients with non-valvular atrial fibrillation receiving oral anticoagulation therapy for stroke prevention

Conclusions Real-world prescriptions do not reflect reported values, suggesting other factors influence patient-physician decision-making around OAC therapy. Data on self-reported adherence to OAC therapy and discordance in the use of OACs from prescribed regimens are concerning and warrant further investigation. Teaser Through a national survey we determined that the preferences of patients and physicians regarding oral anticoagulant (OAC) therapy for stroke prevention in atrial fibrillation differed, but largely focused on characteristics related to safety. However, real-world prescriptions do not reflect the reported values, suggesting other factors influence patient-physician decision-making around OAC therapy. Data on self-reported adherence to OAC therapy and discordance in the use of OACs from prescribed regimens were identified and warrant further investigation.
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research